Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC22A2 | O15244 | 1/20 | 0.30 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.30 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.30 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.30 |
| ▸ | STAT6 | P42226 | 1/20 | 0.30 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.30 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.30 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.30 |
| ▸ | GRIN2C | Q14957 | 1/20 | 0.30 |
| ▸ | GRIN3A | Q8TCU5 | 1/20 | 0.30 |
| ▸ | SLC47A1 | Q96FL8 | 1/20 | 0.30 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16930820 | 1.00 | SLC22A2 (0.30) | SLC22A2SLC22A1GRIN2DGRIN3BLMNA | |
| SCHEMBL3849835 | 0.83 | — | — | |
| SCHEMBL18028703 | 0.79 | LMNA (0.34) | SLC22A2SLC22A1GRIN2DGRIN3BLMNA | |
| SCHEMBL3849693 | 0.79 | LMNA (0.36) | SLC22A2SLC22A1GRIN2DGRIN3BLMNA | |
| SCHEMBL3849632 | 0.77 | — | — | |
| SCHEMBL11657632 | 0.71 | GRIN2D (0.41) | SLC22A2GRIN2DGRIN3BGRIN1GRIN2A | |
| SCHEMBL13109254 | 0.71 | — | — | |
| SCHEMBL8680357 | 0.69 | GRIN2D (0.44) | SLC22A2SLC22A1GRIN2DGRIN3BLMNA | |
| SCHEMBL258925 | 0.69 | GRIN2D (0.44) | SLC22A2SLC22A1GRIN2DGRIN3BLMNA | |
| SCHEMBL4999951 | 0.67 | GRIN2D (0.42) | SLC22A2SLC22A1GRIN2DGRIN3BLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-104628526-B | A kind of preparation method of adamantane triol | 徐州博康信息化学品有限公司 | 2016-09-07 | — | — | CN | claimed |
| US-4990691-A | Hydrolyzing tribromoadamantane in presence of pyridine to form triol | IDEMITSU KOSAN COMPANY LIMITED (JP) | 1991-02-05 | — | — | US | claimed |
| US-11708384-B2 | Systems and methods for mechanosynthesis | CBN NANO TECHNOLOGIES INC. (CA) | 2023-07-25 | — | — | US | disclosed |
| US-20220106338-A1 | Systems and Methods for Mechanosynthesis | CBN NANO TECHNOLOGIES INC. (CA) | 2022-04-07 | — | — | US | disclosed |
| US-11203726-B1 | Diamondoid fuels | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) | 2021-12-21 | — | — | US | disclosed |
| US-11118124-B1 | Diamondoid fuels | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) | 2021-09-14 | — | — | US | disclosed |
| CN-107324978-B | Biphenyl substituted adamantane derivative monomolecular resin, positive photoresist composition and negative photoresist composition | 中国科学院理化技术研究所 | 2020-10-02 | — | — | CN | disclosed |
| US-10710941-B1 | Diamondoid fuels | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) | 2020-07-14 | — | — | US | disclosed |
| CN-107266319-B | Dendritic polyphenyl substituted adamantane derivative monomolecular resin, positive photoresist composition and negative photoresist composition | 中国科学院理化技术研究所 | 2020-04-24 | — | — | CN | disclosed |
| CN-107266319-A | Dendritic polyphenyl substituted adamantane derivative monomolecular resin, positive photoresist composition and negative photoresist composition | 中国科学院理化技术研究所 | 2017-10-20 | — | — | CN | disclosed |
| US-9716235-B2 | 9,10-bis[2-(p-substituted phenyl)pyrimidin-4-yl] anthracene compounds, methods of preparing the same, organic electroluminescent devices and organic electroluminescent display apparatus | BOE TECHNOLOGY GROUP CO., LTD. (CN) | 2017-07-25 | — | — | US | disclosed |
| EP-1985616-A1 | ADAMANTANE DERIVATIVE, RESIN COMPOSITION CONTAINING SAME, AND OPTOELECTRONIC MEMBER AND SEALING AGENT FOR ELECTRONIC CIRCUIT USING THOSE | Idemitsu Kosan Co., Ltd. (JP) | 2008-10-29 | — | — | EP | disclosed |
| US-6720460-B2 | FORMING HEAT RESISTANT, MECHANICAL STRENGTH POLYMER ADDITIVES; ACID CATALYZED REACTION OF ADAMANTANE DIOL OR TRIOL WITH PHENOLIC DERIVATIVE | HONSHU CHEMICAL INDUSTRY CO., LTD. (JP) | 2004-04-13 | — | — | US | disclosed |
| US-20030187307-A1 | Hydroxyphenyl adamantanes and process for the production of the same | HONSHU CHEMICAL INDUSTRY CO., LTD. (JP) | 2003-10-02 | — | — | US | disclosed |
| EP-1336597-A1 | Hydroxyphenyl adamantanes and process for the production of the same | Honshu Chemical Industry Co., Ltd. (JP) | 2003-08-20 | — | — | EP | disclosed |
| US-20010014428-A1 | Chemically amplified positive resist composition | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2001-08-16 | — | — | US | disclosed |
| US-5017734-A | Ethynyl adamantane derivatives and methods of polymerization thereof | FLUOROCHEM INC., A CORP. OF CALIFORNIA | 1991-05-21 | — | — | US | disclosed |
| US-4990691-A | Hydrolyzing tribromoadamantane in presence of pyridine to form triol | IDEMITSU KOSAN COMPANY LIMITED (JP) | 1991-02-05 | — | — | US | disclosed |
| US-4963292-A | HIGH VISCOSITY AT ELEVATED TEMPERATURES; LOW POUR POINT; HEAT AND OXIDATION RESISTANCE | IDEMITSU KOSAN COMPANY, LIMITED (JP) | 1990-10-16 | — | — | US | disclosed |
| EP-0363866-A2 | Higher carboxylic acid triester of adamantane triol and lubricating oil containing the same | IDEMITSU KOSAN COMPANY LIMITED (JP) | 1990-04-18 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11118124-B1 | Diamondoid fuels | COXFA4, DCAF15, PC | SLC22A2 2099/4885SLC22A1 2311/4885GRIN2D 3334/4885 |
| US-20030187307-A1 | Hydroxyphenyl adamantanes and process for the production of the same | CYP8B1, DHPS, P4HA1 | SLC22A2 2800/4885SLC22A1 2007/4885GRIN2D 2144/4885 |
| US-11203726-B1 | Diamondoid fuels | COXFA4, DCAF15, PC | SLC22A2 2099/4885SLC22A1 2311/4885GRIN2D 3334/4885 |
| US-10710941-B1 | Diamondoid fuels | COXFA4, DCAF15, PC | SLC22A2 2099/4885SLC22A1 2311/4885GRIN2D 3334/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.